Is National Institutes of Biomedical Innovation, Health and Nutrition's patent grant rate increasing or decreasing?

National Institutes of Biomedical Innovation, Health and Nutrition's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Institutes of Biomedical Innovation, Health and Nutrition

Q: Where does National Institutes of Biomedical Innovation, Health and Nutrition rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Institutes of Biomedical Innovation, Health and Nutrition ranks #14,803 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the National Institutes of Biomedical Innovation, Health and Nutrition patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 20 granted patents across 18 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #14,803 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 18 technology areas.

#14,803
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 9.6
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14803 · Foreign Corporation #14,803 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,803/49,997
PHOTO-FINISH Najing Technology
CPC-FOCUS A61P · 18 areas
INNOV-PAR 41.9/100
CLAIMS-PAR 9.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Najing Technology Corporation Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (25%) Velocity 10.7 pts (25%) Breadth 15.0 pts (36%) Claim depth 5.8 pts (14%)

Qualcomm Incorporated · highest

85
National Institutes… · this assignee

42
3D Lighting… · lowest

7

What this shows National's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 9.6 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Institutes of Biomedical Innovation, Health and Nutrition is a focused PatentsView assignee: 18 CPC subclasses with 65% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2017. By volume, National sits between Najing Technology Corporation Ltd. and Network Performance Research Group LLC.

National's three-year grant acceleration

National Institutes of Biomedical Innovation, Health and Nutrition shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Najing Technology

20
National Institut…

20
National Institut…

20
National Institut…

20
National Universi…

20
Nautilus True

20
Neosensory

20
Network Performan…

20
National Institut… ◀

20

What this shows National holds 20 patents at rank #14,803, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #14,803 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

National Institutes of Biomedical Innovation, Health and Nutrition patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	5.0%
2018	1	5.0%
2019	1	5.0%
2021	4	20.0%
2022	5	25.0%
2023	1	5.0%
2024	2	10.0%
2025partial year	5	25.0%

Which technologies does National Institutes of Biomedical Innovation, Health and Nutrition patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C07K - Peptides 8

Y02A - Technologies FOR Adaptation TO Climate Change 5

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C12Y - Enzymes 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

G06V - Image OR Video Recognition OR Understanding 1

G02B - Optical Elements, Systems OR Apparatus 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

G06T - Image Data Processing OR Generation, IN General 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Institutes of Biomedical Innovation, Health and Nutrition's patent record in context - here's where to go next.

National Institutes of Biomedical Innovation, Health and Nutrition's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 65% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #14,803 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Institutes of Biomedical Innovation, Health and Nutrition against Najing Technology Corporation Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.